Industrial Insights

Fluorinated Building Blocks in Drug Design

Published 2025-05-12

Fluorine substitution changes metabolic stability, acidity and binding.

Introducing fluorine into a drug candidate modifies metabolic stability, membrane permeability and the acidity of nearby functional groups. Fluorinated building blocks such as fluoroarenes and trifluoromethyl aromatics let medicinal chemists install these effects early in the route rather than late-stage fluorination.

Related Compounds

C7H7F
4-FluorotolueneFluorinated Compounds
CAS 352-32-9C7H7FMW 110.13
View Details
C6H5F
FluorobenzeneFluorinated Compounds
CAS 462-06-6C6H5FMW 96.1
View Details

Related Knowledge Articles

Pharmaceutical Intermediates

Quality Control of Pharmaceutical Intermediates

Identity, assay, impurity profile and residual solvents are the four pillars.

CRO / CDMO

Choosing a CRO or CDMO Partner

Evaluation criteria for outsourcing synthesis and manufacturing.

Drug Development

Scale-Up From Gram to Kilogram

What changes when a laboratory route moves into a pilot plant.

Looking for a Specific Compound?

Send us your CAS Number, chemical structure or project requirements and our scientific team will evaluate your request.

Request a Quote